Labcorp Drug Development offered in-house, fully integrated DCT capabilities, the sponsor came to us for solutions. Specifically, the sponsor wanted greater flexibility in trial conduct.

We're committed to advancing your cardiovascular study with the best resources, from our in-house cardiology specialists to our vast global clinical trial data insights.

Labcorp MCS is a suite of solutions that aims to reduce the patient burden of studies while also providing flexibility to the investigator sites.

National AALAS 2022 -- Compassion fatigue is a common occurrence in the fields of veterinary medicine and animal testing, such that most workers have been impacted either directly or indirectly. Animal euthanasia, night work, weekend/holiday work and challenging study designs are some examples of things that can cause compassion fatigue.

National AALAS 2022 -- Restraining a rabbit for various dosing routes and blood collection can be difficult with a myriad of items needing to be considered; from the animal's fragility to their ability to kick and injure technicians, and technician safety to animal welfare.

Labcorp Drug Development (LDD) is experienced in overcoming RA clinical trial challenges. We have and established patient support system, including health education and appointment reminders. LDD Voice of Patient insights are used in trial design to ensure compliance and retention.

Seven drugs have been approved for treatment of chronic hepatitis B virus (HBV), but most patients still require lifelong therapy with virally targeted drugs.

ISPOR Europe 2022 -- Traditionally, tumors have been treated based on their site of origin rather than their specific characteristics.

ISPOR Europe 2022 -- China's near-universal drug coverage has limitations due to high out-of-pocket costs for patients and poor coverage of innovative, premium-priced medicines. To increase access to high-cost innovative drugs, national drug price negotiations were introduced in 2015.

ISPOR Europe 2022 -- Patient engagement in health technology assessment (HTA) appraisals is important to identify unmet needs, ensure the authorisation of safe and effective treatments and enhance the implementation of patient-centered care leading to better health outcomes.